Novartis Drug Heralds Multiple Sclerosis Advances (Update2) - Bloomberg

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service86 times read : Adjust font size: Decrease font Enlarge font
image

April 27 (Bloomberg) -- The first in a new wave of multiple sclerosis medicines, from drugmakers led by Novartis AG and Merck KGaA , may reach the market next year, making therapy more convenient for patients and boosting profits. In Seattle this ...

Read this article...



Post your comment comment Comments (0 posted)

copyright